Roche: FDA designation for blood test - MarketScreener

Roche announces that its Tina-quant lipoprotein Lp RxDx test has been designated a breakthrough device by the U.S. FDA to identify patients likely to benefit from an innovative Lp-lowering therapy...

Related Keywords

Switzerland ,Swiss , ,Amgen ,Roche Diagnostics ,